Unique ID issued by UMIN | UMIN000050678 |
---|---|
Receipt number | R000057740 |
Scientific Title | A prospective observational study on host immunity for development of novel immunotherapeutic strategy for treatment and prevention of postoperative infections |
Date of disclosure of the study information | 2023/03/27 |
Last modified on | 2023/03/26 15:38:42 |
A prospective observational study on host immunity for development of novel immunotherapeutic strategy for treatment and prevention of postoperative infections
An observational study on immunity in patients with postoperative infections
A prospective observational study on host immunity for development of novel immunotherapeutic strategy for treatment and prevention of postoperative infections
An observational study on immunity in patients with postoperative infections
Japan |
- Respiratory, digestive, and cardiovascular diseases scheduled for surgery
- Postoperative infections
Medicine in general | Pneumology | Surgery in general |
Others
YES
To reveal the host immune characteristics in patients with postoperative infections
Others
To make recommendations/suggestions to develop strategies for treatment and prevention of postoperative infections
Exploratory
Explanatory
Not applicable
1) Clinical outcome:
Onset of postoperative infections within 30 days after surgery
2) Immunological outcome:
Association between host immune characteristics and clinical outcomes
Observational
20 | years-old | <= |
90 | years-old | >= |
Male and Female
Patients scheduled for surgery for respiratory, gastrointestinal, cardiovascular, or other diseases.
-Age: 20 and older
-Patients within 1 months of recovery from an acute infection
-Patients with chronic hepatic disorders due to HBV or HCV infections.
-HIV-positive patients
-Patients previously treated with chemotherapy, immune checkpoint inhibitors, or radiation therapy for malignant tumors.
-Patients with active multiple cancers.
-Patients with active hematologic malignancies.
-Patients with hemoglobin level <= 10 g/dL.
-Patients after blood stem cell transplants, including bone marrow transplants.
-Patients treated for co-morbidities with high-dose glucocorticoid, immunosuppressive drugs, or biological agents.
-Elderly patients who are 90 years old or older.
-Pregnant women.
75
1st name | Makoto |
Middle name | |
Last name | Ishii |
Nagoya University Graduate School of Medicine
Respiratory Medicine
466-8550
65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
0527442167
mishii@med.nagoya-u.ac.jp
1st name | Yuichiro |
Middle name | |
Last name | Shindo |
Nagoya University Hospital
Respiratory Medicine
466-8550
65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
0527442167
yshindo@med.nagoya-u.ac.jp
Nagoya University
Yuichiro Shindo
Japan Society for the Promotion of Science
Japanese Governmental office
Japan
Nagoya University Hospital, Institutional Review Board
65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
052-744-2423
iga-shinsa@adm.nagoya-u.ac.jp
NO
名古屋大学医学部附属病院(愛知県)
2023 | Year | 03 | Month | 27 | Day |
Unpublished
Enrolling by invitation
2022 | Year | 10 | Month | 24 | Day |
2023 | Year | 03 | Month | 10 | Day |
2023 | Year | 03 | Month | 27 | Day |
2027 | Year | 03 | Month | 31 | Day |
- This study is an observational study.
- Clinical information and blood samples will be collected at Nagoya University Hospital. Immunological analyses of blood samples will be performed at Nagoya University Graduate School of Medicine.
2023 | Year | 03 | Month | 26 | Day |
2023 | Year | 03 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057740